[What are the safety measures for use of low-molecular-weight heparins in the treatment of deep venus thrombosis?].
作者信息
Fiessinger J N
出版信息
Presse Med. 2000 Apr 8;29(13):766-8.
PMID:10797834
Abstract
摘要
相似文献
1
[What are the safety measures for use of low-molecular-weight heparins in the treatment of deep venus thrombosis?].
Presse Med. 2000 Apr 8;29(13):766-8.
2
Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
Dis Mon. 2005 Feb-Mar;51(2-3):150-7. doi: 10.1016/j.disamonth.2005.03.010.
3
Low-molecular-weight heparin for treating venous thromboembolism.
Ann Intern Med. 1999 Jan 5;130(1):77-8. doi: 10.7326/0003-4819-130-1-199901050-00024.
4
Deep venous thrombosis: outpatient therapy with low-molecular-weight heparin.
Manag Care. 1999 Dec;8 Suppl:2-6.
5
Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
Crit Care Clin. 2005 Jul;21(3):497-512. doi: 10.1016/j.ccc.2005.05.004.
6
The treatment of deep venous thrombosis, including the newer agents.
Dis Mon. 2005 Feb-Mar;51(2-3):104-11. doi: 10.1016/j.disamonth.2005.03.004.
7
[Use of LMW heparin: information for prescribers. Update: 10 April 2002].
J Mal Vasc. 2002 Oct;27(4):231-3.
8
Safety of low molecular weight heparins in the treatment of venous thromboembolism.
Expert Opin Drug Saf. 2003 Jan;2(1):87-94. doi: 10.1517/14740338.2.1.87.
9
Low-molecular-weight heparin in outpatient treatment of DVT.
Am Fam Physician. 1999 Feb 15;59(4):945-52.
10
[Use of low-molecular-weight heparins in patients with prosthetic heart valves].
Dtsch Med Wochenschr. 2003 May 16;128(20):1129-33. doi: 10.1055/s-2003-39258.
Zotero 插件